Understanding women's experience with self-induced abortion and follow-up after harm-reduction counseling: A qualitative study
We conducted semi-structured, qualitative interviews with 22 women who presented for harm-reduction counseling in 2012, including 20 who used misoprostol. Women were recruited following participation in a telephone survey and purposively sampled by misoprostol use and follow-up type. Interviews were conducted and analyzed in Spanish.
Women across pregnancy outcomes and follow-up types felt better informed after harm-reduction counseling, and were grateful for the lack of judgment of their circumstances and decisions. Women had uncertainty and fear regarding how to use misoprostol and what to expect, but many said that the counseling eased their concerns. Even so, many still reported visiting several pharmacies, being turned away for lack of a prescription, or being sold fewer pills than needed, and a few felt judged. Many women obtained an ultrasound after self-inducing, as advised by the counselor, but some women delayed or forwent an ultrasound because they could not afford the fee, including several who experienced ongoing bleeding. Some women whose self-induction was uneventful sought no follow-up services.
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Public health or related research
Describe the harm-reduction model for abortion as implemented in Peru Explain Peruvian women’s experiences self-inducing abortion after receiving harm-reduction counseling
Keyword(s): Women's Health, Abortion
Qualified on the content I am responsible for because: I am a Senior Project Manager at Ibis Reproductive Health which specializes in social science research addresses women's access to abortion care. I oversaw data collection and analysis for the project being presented. I work closely with the reproductive health clinics in Peru where the harm-reduction counseling takes place.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.